Skip to main content
Neocortical β-amyloid area is associated with dementia and APOE in the oldest-old.
- Author(s): Berlau, Daniel J;
- Corrada, María M;
- Robinson, John L;
- Geser, Felix;
- Arnold, Steven E;
- Lee, Virginia M-Y;
- Kawas, Claudia H;
- Trojanowski, John Q
- et al.
Published Web Locationhttps://doi.org/10.1016/j.jalz.2012.11.011
ObjectiveApolipoprotein E (APOE) ε2 carriers may be protected from dementia because of reduced levels of cortical β-amyloid. In the oldest-old, however, APOE ε2 carriers have high β-amyloid plaque scores and preserved cognition. We compared different measures of β-amyloid pathology across APOE genotypes in the oldest-old, and their relationship with dementia.
MethodsThe study included 96 participants from The 90+ Study. Using all information, dementia diagnoses were made. Neuropathological examination included staging for amyloid plaques and β-amyloid cortical percent area stained by NAB228 antibody.
ResultsBoth APOE ε2 and APOE ε4 carriers had high Consortium to Establish a Registry for Alzheimer's Disease plaque scores. However, APOE ε2 carriers had low cortical β-amyloid percent areas. β-amyloid percent area was associated with dementia across APOE genotypes.
ConclusionsLower levels of percent area in APOE ε2 carriers may reflect lower total β-amyloid and may contribute to APOE ε2 carriers' decreased risk of dementia, despite high β-amyloid plaque scores. The relationship between β-amyloid plaques and dementia in the oldest-old may vary by APOE genotype.
For improved accessibility of PDF content, download the file to your device.